These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29637585)

  • 1. Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection.
    Kuhnhenn L; Jiang B; Kubesch A; Vermehren J; Knop V; Susser S; Dietz J; Carra G; Finkelmeier F; Grammatikos G; Zeuzem S; Sarrazin C; Hildt E; Peiffer KH
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1523-1535. PubMed ID: 29637585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis B.
    Yan LB; Zhu X; Bai L; Tang XQ; Du LY; Chen EQ; Liang LB; Tang H
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):296-302. PubMed ID: 27988305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India.
    Chauhan R; Kazim SN; Bhattacharjee J; Sakhuja P; Sarin SK
    J Med Virol; 2006 Aug; 78(8):1047-54. PubMed ID: 16789012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
    Bayliss J; Yuen L; Rosenberg G; Wong D; Littlejohn M; Jackson K; Gaggar A; Kitrinos KM; Subramanian GM; Marcellin P; Buti M; Janssen HLA; Gane E; Sozzi V; Colledge D; Hammond R; Edwards R; Locarnini S; Thompson A; Revill PA
    Gut; 2017 Nov; 66(11):2013-2023. PubMed ID: 27534671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
    Sonneveld MJ; Rijckborst V; Zeuzem S; Heathcote EJ; Simon K; Senturk H; Pas SD; Hansen BE; Janssen HL
    Hepatology; 2012 Jul; 56(1):67-75. PubMed ID: 22307831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers.
    Qin Y; Zhang J; Mao R; Guo H; Yin Y; Wu X; Weng X; Wands J; Tong S
    J Med Virol; 2009 May; 81(5):807-14. PubMed ID: 19319958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.
    Abbas Z; Muzaffar R; Siddiqui A; Naqvi SA; Rizvi SA
    BMC Gastroenterol; 2006 Jul; 6():20. PubMed ID: 16863587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.
    Lapalus M; Laouenan C; Cardoso AC; Estrabaud E; Carvalho-Filho RJ; Zhang Q; Lada O; Appourchaux K; Mouri F; Boyer N; Bedossa P; Asselah T; Martinot-Peignoux M; Marcellin P
    Liver Int; 2015 Sep; 35(9):2082-9. PubMed ID: 25612083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients.
    Castelain S; Descamps V; Brochot E; Helle F; Duverlie G; Nguyen-Khac E; François C
    Arch Virol; 2017 Jul; 162(7):1913-1920. PubMed ID: 28289975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The loss of HBeAg without precore mutation results in lower HBV DNA levels and ALT levels in chronic hepatitis B virus infection.
    Kawabe N; Hashimoto S; Harata M; Nitta Y; Murao M; Nakano T; Shimazaki H; Arima Y; Komura N; Kobayashi K; Yoshioka K
    J Gastroenterol; 2009; 44(7):751-6. PubMed ID: 19430716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
    Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
    Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
    Kamijo N; Matsumoto A; Umemura T; Shibata S; Ichikawa Y; Kimura T; Komatsu M; Tanaka E
    World J Gastroenterol; 2015 Jan; 21(2):541-8. PubMed ID: 25593470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus.
    Pivert A; Servant-Delmas A; Lunel-Fabiani F; Le Guillou-Guillemette H; Laperche S; Ducancelle A
    J Med Virol; 2015 Mar; 87(3):529-35. PubMed ID: 25170961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precise analysis of the effect of basal core promoter/precore mutations on the main phenotype of chronic hepatitis B in mouse models.
    Liu Y; Zhao ZH; Lv XQ; Tang YW; Cao M; Xiang Q; Wu Y; Zhang HT; Lai GQ
    J Med Virol; 2020 Dec; 92(12):3412-3419. PubMed ID: 32427358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland.
    Grabarczyk P; Garmiri P; Liszewski G; Doucet D; Sulkowska E; Brojer E; Allain JP;
    J Viral Hepat; 2010 Jun; 17(6):444-52. PubMed ID: 19780948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?
    Chakrabarty G; Bruce M; Horner M; Wang B; Agarwal K; Carey I
    J Viral Hepat; 2018 Jan; 25(1):80-87. PubMed ID: 28710798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
    Boyd A; Moh R; Maylin S; Abdou Chekaraou M; Mahjoub N; Gabillard D; Anglaret X; Eholié SP; Delaugerre C; Danel C; Zoulim F; Lacombe K;
    J Viral Hepat; 2018 Oct; 25(10):1121-1131. PubMed ID: 29660214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients.
    Wang XL; Ren JP; Wang XQ; Wang XH; Yang SF; Xiong Y
    World J Gastroenterol; 2016 Mar; 22(11):3268-74. PubMed ID: 27004005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.
    Boglione L; D'Avolio A; Cariti G; Gregori G; Burdino E; Baietto L; Cusato J; Ghisetti V; De Rosa FG; Di Perri G
    Liver Int; 2013 Apr; 33(4):580-5. PubMed ID: 23311449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.